Leon H Kircik MD

Dermatology•Louisville, KY

Dermatologic Surgery

Physician

Join to View Full Profile

1169 Eastern Pkwy 2310Louisville, KY 40217
Phone+1 502-456-2783
Fax+1 502-456-2728

Education & Training

University of Wisconsin Hospitals and ClinicsResidency, Surgery, 1994 - 1994
University at Buffalo School of MedicineResidency, Dermatology, 1990 - 1993
Westchester Medical CenterInternship, Internal Medicine, 1989 - 1990
State University of New York Downstate Medical Center College of MedicineClass of 1989

Certifications & Licensure

NJ State Medical License 1993 - Present
KY State Medical License 1996 - 2026
NY State Medical License 1990 - 2026
TX State Medical License 2022 - 2026
VA State Medical License 1998 - 2026
IN State Medical License 1998 - 2025
WI State Medical License 1994 - 2025
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology
Fellow (FASDS) American Society for Dermatologic Surgery

Clinical Trials

A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis Start of enrollment: 2006 Mar 01
Completed
Phase 4
Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis Start of enrollment: 2007 Feb 01
Completed
Phase 2
A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitis Start of enrollment: 2010 Feb 01
Completed
Phase 4
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
Completed
Phase 3
Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study Start of enrollment: 2014 May 01
Completed
Phase 4
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris Start of enrollment: 2015 Apr 01
Completed
Phase 2
Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy Start of enrollment: 2016 Dec 29
Completed
Phase 4
The Use of Oracea and Epiduo Forte in Severe Acne Patients Start of enrollment: 2018 Mar 19
Completed
Phase 4
The Maintenance Effect of Enstilar Foam in Combination With Otezla Start of enrollment: 2020 Jun 24
Recruiting
Phase 4
Roles: Principal Investigator, Contact
POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis Start of enrollment: 2023 Jul 31
COMPLETED
PHASE2
Roles: Contact
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
ACTIVE_NOT_RECRUITING
PHASE3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: poole...
Andrew Blauvelt, Leon Kircik, Todd Schlesinger, Evangeline Pierce, Russel Burge
The Journal of Dermatological Treatment. 2025-12-01
One Acne™: A holistic management approach to improve overall skin quality and treatment outcomes in acne with or without sensitive skin.
Leon Kircik, Jerry Tan, Edward Ted Lain, Katie Beleznay, Rajeev Chavda
International Journal of Dermatology. 2025-04-01
Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials.
April W Armstrong, Leon Kircik, Linda Stein Gold, Bruce Strober, Claudia H M C De Oliveira
Dermatology and Therapy. 2025-04-01

Journal Articles

Trial of Roflumilast Cream for Chronic Plaque Psoriasis
Leon H Kircik, Steven E Kempers, Howard Welgus, The New England Journal of Medicine

Lectures

Acne and Rosacea
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/3/2019

Authored Content

Polymorphous Light Eruptions Treated with Roflumilast 0.3% Cream: A Case ReportAugust 2024
Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion With a Ceramide-Containing Moisturizer in Adults With PsoriasisJanuary 2024
Trial of Roflumilast Cream for Chronic Plaque PsoriasisJuly 2020

Press Mentions

Patient Preferences in Topical Psoriasis TreatmentMarch 18th, 2023
Intralesional Mode of Drug Administration in PsoriasisJanuary 26th, 2022
LiVDerm Announces New South Beach Symposium Planning Committee & Advisory BoardApril 20th, 2021
Join now to see all